PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsjuvenile arthritis
MeSH D001171 - juvenile arthritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012216:Rheumatic diseases
$
Success rate
D001168:Arthritis
$
Success rate
D001327:Autoimmune diseases
$
Success rate
D001171: 
Juvenile arthritis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaNaproxen Naproxen  1995-02-28   
Diclofenac Diclofenac  1996-08-15   
Ibuprofen, Hydrocodone Hydrocodone Ibuprofen  2003-04-11   
Ibuprofen Ibuprofen  1986-09-23   
Famotidine, Ibuprofen Ibuprofen Famotidine  2021-10-29   
Diclofenac Diclofenac Potassium  1998-08-06   
Glenmark PharmaceuticalsNaproxen Naproxen  2007-03-28   
Diclofenac Diclofenac  2016-09-13   
Acetaminophen, Ibuprofen Acetaminophen Ibuprofen  2024-04-26   
BioconAdalimumab Hulio  2020-07-06   
MylanNaproxen Naproxen  1993-12-21   
Esomeprazole, Naproxen Naproxen Esomeprazole Magnesium  2021-07-20   
Ibuprofen Ibuprofen  1985-09-24   
Methotrexate Methotrexate  1992-05-15   
Johnson & JohnsonIbuprofen Ibuprofen  1986-06-16   
Ibuprofen, Pseudoephedrine Motrin  1984-05-18   
Ibuprofen, Pseudoephedrine Sine-aid  1992-12-31   
PerrigoNaproxen Naproxen  1997-01-13   
Naproxen, Diphenhydramine Naproxen Diphenhydramine  2019-05-10   
Pseudoephedrine, Naproxen Naproxen Pseudoephedrine  2004-03-17   
Diclofenac Diclofenac  2019-05-16   
Ibuprofen Cap-profen  1987-12-08   
Ibuprofen Ibuprofen  1987-12-08   
Ibuprofen, Diphenhydramine Ibuprofen Diphenhydramine  2008-12-22   
Ibuprofen, Phenylephrine Ibuprofen Phenylephrine  2014-07-03   
Ibuprofen, Pseudoephedrine Ibuprofen Pseudoephedrine  2003-11-05   
Ibuprofen Tab-profen  1987-12-08   
Acetaminophen, Ibuprofen Acetaminophen Ibuprofen  2023-02-28   
P&L Developments (PLD)Ibuprofen Ibuprofen  1986-09-19   
Naproxen, Diphenhydramine Naproxen Diphenhydramine  2019-01-25   
RocheTocilizumab RoActemra  2009-01-15   
CiplaNaproxen Naproxen  2011-08-24   
Diclofenac Diclofenac  2018-08-03   
SandozEtanercept Erelzi  2016-08-30   
Adalimumab Halimatoz  2018-07-26   
Adalimumab Hefiya  2018-07-26   
Adalimumab Hyrimoz  2018-10-30   
Naproxen Naproxen  1993-12-21   
Diclofenac Diclofenac  2008-02-06   
Diclofenac, Misoprostol Diclofenac Misoprostol  2013-05-09   
Ibuprofen Ibuprofen  1988-02-25   
Methotrexate Methotrexate  2009-03-31   
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
81%
13/16
Phase 2
55%
6/11
Phase 3
64%
30/47
Approved: 19Overall Success rate: 28%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
...
10
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use